We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

99 hedge funds and large institutions have $140M invested in Cytokinetics in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 27 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 27

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

5% more funds holding

Funds holding: 94 → 99 (+5)

9% more call options, than puts

Call options by funds: $2.41M | Put options by funds: $2.21M

5% more capital invested

Capital invested by funds: $133M → $140M (+$6.59M)

Holders
99
Holders Change
+5
Holders Change %
+5.32%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
44
Reduced
27
Closed
10
Calls
$2.41M
Puts
$2.21M
Net Calls
+$202K
Net Calls Change
+$142K

Top Buyers

Rank Fund Capital Flow
1
TC
TFS Capital
Pennsylvania
+$4.72M
2
SFM
Sphera Funds Management
Israel
+$2.77M
3
Millennium Management
Millennium Management
New York
+$1.18M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$681K
5
NI
Numeric Investors
Massachusetts
+$632K

Top Sellers

Rank Fund Capital Flow
1
IIM
Ironwood Investment Management
Massachusetts
-$1.15M
2
GCP
GSA Capital Partners
United Kingdom
-$1.13M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.06M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$899K
5
HCM
Highbridge Capital Management
New York
-$746K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$879K +$681K +103,813 +384%
BIM
27
BlackRock Investment Management
Delaware
$870K +$98.8K +15,062 +13%
PAI
28
Palo Alto Investors
California
$831K – – –
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$784K -$7.12K -1,086 -0.9%
BIM
30
Bogle Investment Management
Massachusetts
$775K +$547K +83,430 +261%
SO
31
STRS Ohio
Ohio
$701K +$300K +45,800 +78%
HVC
32
Healthcare Value Capital
New Jersey
$672K – – –
Deutsche Bank
33
Deutsche Bank
Germany
$669K -$177K -26,984 -21%
NCCM
34
Nine Chapters Capital Management
New Jersey
$667K -$494K -75,400 -43%
NFA
35
Nationwide Fund Advisors
Ohio
$646K -$240K -36,539 -28%
Creative Planning
36
Creative Planning
Kansas
$626K +$610K +93,026 +112,080%
SIP
37
Stoneridge Investment Partners
Pennsylvania
$599K +$170K +25,869 +41%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$556K -$192K -29,300 -26%
FIM
39
Freedom Investment Management
Connecticut
$554K +$156K +23,854 +41%
EGA
40
Eagle Global Advisors
Texas
$515K +$324K +49,450 +182%
AG
41
Algert Global
California
$492K – – –
Renaissance Technologies
42
Renaissance Technologies
New York
$487K +$19.2K +2,933 +4%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$475K -$298K -45,500 -39%
Wells Fargo
44
Wells Fargo
California
$434K +$84.6K +12,903 +25%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$433K +$240K +36,648 +132%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$425K +$1.89K +288 +0.5%
TI
47
Trexquant Investment
Connecticut
$378K +$369K +56,300 New
KeyBank National Association
48
KeyBank National Association
Ohio
$360K – – –
Charles Schwab
49
Charles Schwab
California
$309K – – –
Alyeska Investment Group
50
Alyeska Investment Group
Illinois
$272K – – –
1
2
3 4 5

CYTK Hedge Fund Activity: Q2 2015 in Review

99 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2015, worth a combined $140M — up 4.9% from $133M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CYTK positions and 10 closed out — a net gain of 5 holders — while 44 added to existing stakes and 27 trimmed.

The largest buyer was TFS Capital, adding an estimated $4.72M. The largest seller was Ironwood Investment Management, cutting an estimated $1.15M.

  • 99 institutional investors held Cytokinetics (CYTK) as of Q2 2015, up from 94 in Q1 2015.
  • Funds reported $140M of Cytokinetics stock for Q2 2015, up 4.9% quarter-over-quarter.
  • 15 funds opened new Cytokinetics positions in Q2 2015 and 10 closed out, a net change of +5 holders.
  • The largest Cytokinetics buyer in Q2 2015 was TFS Capital, an estimated $4.72M added.
  • The largest Cytokinetics seller in Q2 2015 was Ironwood Investment Management, an estimated $1.15M sold.

Based on aggregated 13F filings for Q2 2015.